CSIMarket
 


Casi Pharmaceuticals inc   (CASI)
Other Ticker:  
 

Cumulative Casi Pharmaceuticals Inc 's Total Debt to Equity for Trailing Twelve Months Period

CASI's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

CASI Total Debt to Equity for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Growth -28.75 % -29.39 % -25.03 % 3.63 % -5.38 %
Y / Y Total Debt Growth 176.75 % -35.34 % - - -
Total Debt to Equity for Trailing Twelve Months Period 0.01 0.01 0.01 0.01 0.01
Total Ranking # 569 # 446 # 502 # 686 # 669
Seq. Equity Growth -7.82 % -10.73 % -11.26 % -2.43 % -8.64 %
Seq. Total Debt Growth 199.7 % - - - -29.97 %


Total Debt to Equity for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite net new borrowings of 199.7% Casi Pharmaceuticals Inc managed to unchange Total Debt to Equity for Trailing Twelve Months Period in III. Quarter to 0.01, below Casi Pharmaceuticals Inc 's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry 23 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Casi Pharmaceuticals Inc . While Total Debt to Equity for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from 446 to 569.

What is Debt to Equity Ratio?
CASI Charts and Quotes
Total Debt to Equity CASI in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 24
Sector # 130
S&P 500 # 568


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.01 0.01 0
(Jun 30 2019)   (Dec 31 2020)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Total Debt to Equity for Trailing Twelve Months Period
Evaxion Biotech A  0.04 
Singular Genomics Systems Inc   0.03 
C4 Therapeutics Inc   0.03 
Miromatrix Medical Inc   0.03 
Century Therapeutics inc   0.03 
Gritstone Bio Inc   0.03 
Biontech Se  0.03 
Ainos Inc   0.02 
Windtree Therapeutics Inc  0.02 
Orion Energy Systems Inc   0.02 
Ocugen Inc   0.02 
Casi Pharmaceuticals inc   0.02 
Hillevax Inc   0.02 
Pulse biosciences inc   0.01 
Polarityte Inc   0.01 
Precipio inc   0.01 
Nutriband Inc   0.01 
Oncocyte Corporation  0.01 
Compass Therapeutics Inc   0.01 
Kiromic Biopharma Inc   0.01 
Inhibikase Therapeutics Inc   0.01 
Vicarious Surgical Inc   0.01 
Applied Uv Inc   0.01 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RSRV's Profile

Stock Price

RSRV's Financials

Business Description

Fundamentals

Charts & Quotes

RSRV's News

Suppliers

RSRV's Competitors

Customers & Markets

Economic Indicators

RSRV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071